Aspirin sensitivity: The role for aspirin challenge and desensitization in postmyocardial infarction patients

被引:19
作者
Schaefer, OP
Gore, JM
机构
[1] Univ Massachusetts, Med Ctr, Div Pulm Allergy & Crit Care Med, Worcester, MA 01655 USA
[2] Univ Massachusetts, Med Ctr, Div Cardiovasc Med, Worcester, MA 01655 USA
关键词
aspirin; allergy; hypersensitivity; myocardial infarction; cardiovascular disease; asthma; urticaria; angioedema;
D O I
10.1159/000006871
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aspirin is one of the world's most commonly used medications and its use benefits many diverse conditions. Adverse reactions, however, are relatively common as well. Hypersensitivity to aspirin can be manifested as acute asthma, urticaria and/or angioedema, or a systemic anaphylactoid reaction. We report 3 cases in whom aspirin was indicated for secondary prophylaxis of myocardial infarction but in whom a remote history of an untoward reaction to it prevented its initial use. These patients all underwent further evaluation of their pulmonary and allergic history and all 3 were challenged with aspirin. Two patients were found not to be sensitive and started on aspirin, the other had a classic asthmatic reaction to the drug and was successfully desensitized to aspirin allowing for its use.
引用
收藏
页码:8 / 13
页数:6
相关论文
共 26 条
  • [1] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
    ALTMAN, R
    CARRERAS, L
    DIAZ, R
    FIGUEROA, E
    PAOLASSO, E
    PARODI, JC
    CADE, JF
    DONNAN, G
    EADIE, MJ
    GAVAGHAN, TP
    OSULLIVAN, EF
    PARKIN, D
    RENNY, JTG
    SILAGY, C
    VINAZZER, H
    ZEKERT, F
    ADRIAENSEN, H
    BERTRANDHARDY, JM
    BRAN, M
    DAVID, JL
    DRICOT, J
    LAVENNEPARDONGE, E
    LIMET, R
    LOWENTHAL, A
    MORIAU, M
    SCHAPIRA, S
    SMETS, P
    SYMOENS, J
    VERHAEGHE, R
    VERSTRAETE, M
    ATALLAH, A
    BARNETT, H
    BATISTA, R
    BLAKELY, J
    CAIRNS, JA
    COTE, R
    CROUCH, J
    EVANS, G
    FINDLAY, JM
    GENT, M
    LANGLOIS, Y
    LECLERC, J
    NORRIS, J
    PINEO, GF
    POWERS, PJ
    ROBERTS, R
    SCHWARTZ, L
    SICURELLA, J
    TAYLOR, W
    THEROUX, P
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921): : 81 - 100
  • [2] BOTEY J, 1984, ANN ALLERGY, V53, P265
  • [3] Burns M., 1997, Journal of the American College of Cardiology, V29, p185A
  • [4] ASPIRIN INTOLERANCE .1. FREQUENCY IN AN ALLERGIC POPULATION
    CHAFEE, FH
    SETTIPANE, GA
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1974, 53 (04) : 193 - 199
  • [5] DALEN JE, 1995, CHEST, V8, pS439
  • [6] ASPIRIN AS A THERAPEUTIC AGENT IN CARDIOVASCULAR-DISEASE
    FUSTER, V
    DYKEN, ML
    VOKONAS, PS
    HENNEKENS, C
    [J]. CIRCULATION, 1993, 87 (02) : 659 - 675
  • [7] Marked reduction in long-term cardiac deaths with aspirin after a coronary event
    Goldstein, RE
    Andrews, M
    Hall, WJ
    Moss, AJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (02) : 326 - 330
  • [8] GRZELEWSKARZYMOWSKA I, 1988, ALLERGOL IMMUNOPATH, V16, P305
  • [9] GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    GUNNAR, RM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (02) : 249 - 292
  • [10] Leukotriene antagonists and synthesis inhibitors: New directions in asthma therapy
    Holgate, ST
    Bradding, P
    Sampson, AP
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (01) : 1 - 13